Interesting cannabis articles and worldwide updates., page-103

Rua Bioscience Confirms First International Order
19/10/2022
http://nzx-prod-s7fsd7f98s.s3-website-ap-southeast-2.amazonaws.com/attachments/RUA/400796/381494.pdf

Rua Bioscience Limited (NZX: RUA) formally announced today that it has received its first order via its German distributer Nimbus Health, marking a significant commercial milestone for the export-focused company.

Managing Director, Anna Stove, says “Receiving this order for dried flower from Nimbus signifies just how close we are to cementing export revenues and providing German patients with a sustainable supply of Rua medicines”.

The order is for Rua’s high THC flower, which has been developed through an extensive R&D programme by Cann Group, Rua’s Australian manufacturing, supply and technical services partner. In Germany, medicinal dried-cannabis flower is prescribed mainly for pain patients (70%), and cannabis flowers with a THC content of greater than 20% make up 77% of cannabis flower prescriptions.

“At its launch, we believe Rua’s flower will be one of the highest THC dried flower medicines on the market, which will give Rua a significant competitive advantage,” she says.